Boyer David W.
Insider CIK 1909817 · NBIX Chief Corp. Affairs Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-09-14 | 2026-09-15 | 826 | $157.45 | $130.1K | 8,722 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-09-14 | 2026-09-15 | 826 | $157.45 | $130.1K | 8,722 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 3,587 | — | $0 | 11,484 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 1,936 | $156.22 | $302.4K | 9,548 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 1,936 | $156.22 | $302.4K | 9,548 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 3,587 | — | $0 | 11,484 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-05-26 | 2026-05-28 | 3,888 | $156.64 | $609.0K | 7,799 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 31,234 | — | $0 | 31,234 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 1,541 | — | $0 | 3,083 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 1,811 | — | $0 | 1,812 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 5,479 | — | $0 | 5,479 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 1,541 | — | $0 | 6,990 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-02-13 | 2026-02-17 | 9,968 | — | $0 | 16,959 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 5,378 | $124.12 | $667.5K | 11,581 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 832 | $124.12 | $103.3K | 6,158 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 1,811 | — | $0 | 7,969 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 978 | $124.12 | $121.4K | 6,991 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-12 | 2026-02-17 | 1,600 | — | $0 | 4,801 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-12 | 2026-02-17 | 1,600 | — | $0 | 6,313 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-12 | 2026-02-17 | 864 | $123.10 | $106.4K | 5,449 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-01-31 | 2026-02-03 | 2,096 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-01-31 | 2026-02-03 | 1,189 | $136.06 | $161.8K | 4,713 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-01-31 | 2026-02-03 | 2,096 | — | $0 | 5,902 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,541 | — | $0 | 4,624 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,811 | — | $0 | 3,623 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,541 | — | $0 | 4,395 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,811 | — | $0 | 3,809 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 830 | $116.69 | $96.9K | 3,565 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 955 | $116.79 | $111.5K | 2,854 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 34,153 | — | $0 | 34,153 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 6,401 | — | $0 | 6,401 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-10 | 2025-02-12 | 700 | $118.31 | $82.8K | 1,998 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-08 | 2025-02-12 | 1,329 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-08 | 2025-02-12 | 1,329 | — | $0 | 2,698 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-01-31 | 2025-02-04 | 2,096 | — | $0 | 2,096 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-01-31 | 2025-02-04 | 1,104 | $152.94 | $168.8K | 1,369 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-01-31 | 2025-02-04 | 2,096 | — | $0 | 2,473 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-10-03 | 2024-10-07 | 1,295 | $113.66 | $147.2K | 377 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-09-13 | 2024-09-17 | 3,461 | $121.88 | $421.8K | 1,672 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 6,165 | — | $0 | 6,165 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 30,977 | — | $0 | 30,977 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 955 | $133.10 | $127.1K | 5,751 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 856 | $133.05 | $113.9K | 4,895 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-08 | 2024-02-08 | 628 | $136.78 | $85.9K | 4,895 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-08 | 2024-02-08 | 700 | $134.19 | $93.9K | 5,523 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-06 | 2024-02-08 | 216 | $141.96 | $30.7K | 4,894 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-06 | 2024-02-08 | 240 | $141.96 | $34.1K | 5,110 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 992 | $140.72 | $139.6K | 4,894 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 1,104 | $140.87 | $155.5K | 5,886 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-10-02 | 2023-10-04 | 1,437 | $112.68 | $161.9K | 4,894 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-30 | 2023-09-01 | 1,438 | $108.22 | $155.6K | 3,460 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-30 | 2023-09-01 | 1,295 | $106.90 | $138.4K | 4,898 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-21 | 2023-08-23 | 1,600 | $107.41 | $171.9K | 6,193 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 45,027 | — | $0 | 45,027 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 7,245 | — | $0 | 7,245 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-08 | 2023-02-08 | 700 | $104.11 | $72.9K | 4,755 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 11,497 | $102.42 | $1.18M | 4,127 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 12,801 | $102.41 | $1.31M | 15,624 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-06 | 2023-02-08 | 240 | $105.61 | $25.3K | 4,127 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-31 | 2023-02-02 | 1,104 | $109.92 | $121.4K | 3,911 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-10-31 | 2022-11-02 | 1,295 | $114.12 | $147.8K | 2,919 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-10-03 | 2022-10-05 | 1,437 | $106.59 | $153.2K | 4,214 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-08 | 2022-02-09 | 700 | $79.62 | $55.7K | 2,919 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 240 | $81.07 | $19.5K | 2,291 | SEC↗ |